NVS has been in the news 750% more than usual
May 30, 2025, 8:32 PM
3.70%
What does NVS do
It seems the content is not visible or provided. Please share the content you'd like summarized, and I'd be happy to help!
NVS has been in the news recently: In the latest quarter, analysts provided mixed ratings for Intellia Therapeutics, indicating varying opinions on the company's performance. Additionally, the FDA approved Alcon Plc’s ALC Tryptyr for treating Dry Eye Disease, while Cooper Companies reported a 14% increase in second-quarter adjusted earnings that exceeded expectations.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
